Receptor Tyrosine Kinase Signaling in the Liver
肝脏中受体酪氨酸激酶信号传导
基本信息
- 批准号:6743663
- 负责人:
- 金额:$ 30.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-06-01 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Receptor tyrosine kinase (RTK) signaling is crucial for many cellular processes, including proliferation, differentiation, cell metabolism, survival and apoptosis. Alterations in growth factor signaling networks can play a pivotal role in carcinogenesis. Despite an explosive growth of our knowledge of protein and lipid components involved in the epidermal growth factor receptor (EGFR) and insulin receptor (IR) signaling, an integrative, quantitative picture of responses of the signaling networks and their control at the cellular level remains poorly understood. The response of hepatocytes to growth factors is the consequence of a complex interplay of multiple protein-protein and protein-lipid interactions, subcellular relocation of signaling proteins and phosphorylation/dephosphorylation reactions. During the previous period of support, our work has demonstrated the considerable potential of a novel cross-disciplinary approach that combines experimental studies with nonlinear systems analysis and interacting computational models to achieve a quantitative understanding of the EGFR and IR signaling networks in hepatocytes. In this application we seek continued support to validate feasible hypotheses suggested by computational modeling, determine the molecular and kinetic factors controlling the different response patterns to EGF and insulin, and understand how cells interpret signals in a context-dependent manner. This knowledge will provide a powerful tool to predict and manipulate critical cellular decisions, which determine cell fate and may, thereby, assist in the development of improved drug therapies. The Specific Aims are: (1) To extend the quantitative analysis of the EGFR signaling network to multiple downstream branches including the Ras/Raf/MEK/ERK pathway in freshly isolated hepatocytes; (2) To modify the EGFR network by the conditional expression of key signaling proteins to desired levels and systematically quantify the impact on EGF-induced signaling in a model cell line; (3) To integrate the insulin receptor (IR) signaling network in the experimental and computational analysis and characterize its interaction with the EGFR pathways in hepatocytes.
描述(由申请人提供):受体酪氨酸激酶(RTK)信号传导对许多细胞过程至关重要,包括增殖、分化、细胞代谢、存活和凋亡。生长因子信号网络的改变在肿瘤发生中起着关键作用。尽管我们对表皮生长因子受体(EGFR)和胰岛素受体(IR)信号传导中所涉及的蛋白质和脂质成分的知识有了爆炸性的增长,但对信号传导网络的反应及其在细胞水平上的控制的综合定量图片仍然知之甚少。肝细胞对生长因子的反应是多种蛋白质-蛋白质和蛋白质-脂质相互作用、信号蛋白的亚细胞重新定位和磷酸化/去磷酸化反应的复杂相互作用的结果。在前一段时间的支持,我们的工作已经证明了相当大的潜力,一种新的跨学科的方法,结合实验研究与非线性系统分析和相互作用的计算模型,以实现定量了解的EGFR和IR信号网络在肝细胞。在这个应用程序中,我们寻求持续的支持,以验证计算建模提出的可行假设,确定控制EGF和胰岛素不同反应模式的分子和动力学因素,并了解细胞如何以上下文相关的方式解释信号。这些知识将提供一个强大的工具来预测和操纵关键的细胞决定,决定细胞的命运,从而可能有助于改进药物治疗的发展。具体目标是:(1)将EGFR信号传导网络的定量分析扩展到多个下游分支,包括新鲜分离的肝细胞中的Ras/Raf/MEK/ERK通路;(2)通过关键信号传导蛋白的条件表达将EGFR网络修饰到所需水平,并系统地定量模型细胞系中对EGF诱导的信号传导的影响;(3)将胰岛素受体(IR)信号网络整合到实验和计算分析中,并表征其与肝细胞EGFR通路的相互作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BORIS N KHOLODENKO其他文献
BORIS N KHOLODENKO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BORIS N KHOLODENKO', 18)}}的其他基金
Mechanisms of Central Autonomic Orchestration of Blood Pressure
中枢自主神经调节血压的机制
- 批准号:
7290920 - 财政年份:2006
- 资助金额:
$ 30.26万 - 项目类别:
Mechanisms of Central Autonomic Orchestration of Blood Pressure
中枢自主神经调节血压的机制
- 批准号:
7249575 - 财政年份:2006
- 资助金额:
$ 30.26万 - 项目类别:
RECEPTOR TYROSINE KINASE SIGNALING IN THE LIVER
肝脏中受体酪氨酸激酶信号传导
- 批准号:
6386510 - 财政年份:2000
- 资助金额:
$ 30.26万 - 项目类别:
Receptor Tyrosine Kinase Signaling in the Liver
肝脏中受体酪氨酸激酶信号传导
- 批准号:
6893422 - 财政年份:2000
- 资助金额:
$ 30.26万 - 项目类别:
Receptor Tyrosine Kinase Signaling in the Liver
肝脏中受体酪氨酸激酶信号传导
- 批准号:
7058750 - 财政年份:2000
- 资助金额:
$ 30.26万 - 项目类别:
RECEPTOR TYROSINE KINASE SIGNALING IN THE LIVER
肝脏中受体酪氨酸激酶信号传导
- 批准号:
6052343 - 财政年份:2000
- 资助金额:
$ 30.26万 - 项目类别:
Receptor Tyrosine Kinase Signaling in the Liver
肝脏中受体酪氨酸激酶信号传导
- 批准号:
6617237 - 财政年份:2000
- 资助金额:
$ 30.26万 - 项目类别:
RECEPTOR TYROSINE KINASE SIGNALING IN THE LIVER
肝脏中受体酪氨酸激酶信号传导
- 批准号:
6520048 - 财政年份:2000
- 资助金额:
$ 30.26万 - 项目类别:
CONTROL OF ENERGY METABOLISM IN CHRONIC ALCOHOLISM
慢性酗酒者能量代谢的控制
- 批准号:
2462814 - 财政年份:1998
- 资助金额:
$ 30.26万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 30.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 30.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 30.26万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 30.26万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 30.26万 - 项目类别:
Studentship